Caricamento...
A Pilot Pharmacologic Biomarker Study in HLA-Haploidentical Hematopoietic Cell Transplant Recipients
PURPOSE: Eleven patients diagnosed with various hematologic malignancies receiving an HLA-haploidentical hematopoietic cell transplant (HCT) participated in an ancillary biomarker trial. The goal of the trial was to evaluate potential pharmacologic biomarkers pertinent to the conditioning regimen (f...
Salvato in:
Autori principali: | , , , , |
---|---|
Natura: | Artigo |
Lingua: | Inglês |
Pubblicazione: |
2013
|
Soggetti: | |
Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3786586/ https://ncbi.nlm.nih.gov/pubmed/23907443 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-013-2232-8 |
Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|